| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/14737159.2.1.17 |
| P8608 | Fatcat ID | release_a7jvt4ra3jelndtqjdyemqqkn4 |
| P698 | PubMed publication ID | 11963798 |
| P2093 | author name string | Robert L Wolfert | |
| Nam W Kim | |||
| Nisha Dada | |||
| P2860 | cites work | HDL, its enzymes and its potential to influence lipid peroxidation. | Q40475176 |
| The oxidation hypothesis of atherosclerosis | Q40625668 | ||
| Lipoprotein-associated PLA2 inhibition--a novel, non-lipid lowering strategy for atherosclerosis therapy | Q43604021 | ||
| P433 | issue | 1 | |
| P921 | main subject | coronary artery disease | Q844935 |
| biomarker | Q864574 | ||
| P304 | page(s) | 17-22 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare | Q15756305 |
| P1476 | title | Lp-PLA2: an emerging biomarker of coronary heart disease | |
| P478 | volume | 2 |
| Q35171257 | Age as a modulator of inflammatory cardiovascular risk factors |
| Q33849524 | Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians |
| Q36524201 | Associations of platelet-activating factor acetylhydrolase gene polymorphisms with risk of ischemic stroke |
| Q88898639 | Atherosclerosis assessment and rheumatoid arthritis |
| Q35225272 | Attenuated age-impact on systemic inflammatory markers in the presence of a metabolic burden |
| Q39354235 | Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study |
| Q35990040 | Candidate-based proteomics in the search for biomarkers of cardiovascular disease |
| Q40280814 | Cloning, expression, and purification of lipoprotein-associated phospholipase A(2) in Pichia pastoris |
| Q37130343 | Distinct urinary lipid profile in children with focal segmental glomerulosclerosis |
| Q39050736 | Elevated plasma platelet-activating factor acetylhydrolase activity and its relationship to the presence of coronary artery disease |
| Q40275828 | Expression and purification of lipoprotein-associated phospholipase A(2), a key enzyme involved in atherosclerosis |
| Q37881966 | From circulating biomarkers to genomics and imaging in the prediction of cardiovascular events in the general population |
| Q33814212 | High density lipoproteins and type 2 diabetes: Emerging concepts in their relationship. |
| Q37987473 | Inflammation, atherosclerosis, and psoriasis. |
| Q88574867 | Interaction between nonsynonymous polymorphisms in PLA2G7 gene and smoking on the risk of coronary heart disease in a Chinese population |
| Q28389004 | Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipids |
| Q37264593 | Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study |
| Q36269180 | Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke |
| Q48125660 | Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach: the North Wuerttemberg and Berlin Infarction Study-II (NOBIS-II). |
| Q36013005 | Lipoprotein-associated phospholipase A2, vascular inflammation and cardiovascular risk prediction |
| Q40587146 | Lipoprotein-associated phospholipase A2: a new marker to determine cardiovascular risk in hypercholesterolemic dyslipidaemic children |
| Q36187055 | Lipoprotein-associated phospholipase A2: a novel marker of cardiovascular risk and potential therapeutic target |
| Q34837405 | Lipoprotein-associated phospholipase A2: a target directed at the atherosclerotic plaque |
| Q34384281 | Lipoprotein-associated phospholipase A₂ is related to plaque stability and is a potential biomarker for acute coronary syndrome |
| Q86757204 | Nonsynonymous polymorphisms in PLA2G7 gene are associated with the risk of coronary heart disease in a southern Chinese population |
| Q36050527 | PLAC test for identification of individuals at increased risk for coronary heart disease. |
| Q35574960 | Pharmacotherapy for dyslipidaemia – current therapies and future agents |
| Q35621992 | Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes |
| Q40170417 | Prevalence of non-alcoholic fatty liver and characteristics in overweight adolescents in the general population |
| Q37617482 | Risk of anaphylaxis in opioid dependent persons: effects of heroin versus substitution substance |
| Q40584187 | Secreted phospholipase A2 enzymes as therapeutic targets |
| Q64064804 | Sympathoexcitation and impaired arterial baroreflex sensitivity are linked to vascular inflammation in individuals with elevated resting blood pressure |
Search more.